Topic Archives: Echo Therapeutics (ECTE)

Today the pitch that’s been catching my eye is from Mitchell Clark for his Biotech Breakthrough Stock Report — we haven’t covered this newsletter before, but we have certainly covered teaser spiels from Mitchell Clark’s wide variety of Lombardi-published newsletters in the past (before he was a biotech expert this week, he was a bible […]

Comments

  • Allison: I find this company a little tough to size up...it is a holding company for several start-ups. It reminds me of...

  • Time to revisit some of the "dogs" in my portfolio… ACELRX PHARMACEUTICALS ($ACRX) - hopes to finish addressing th...

  • Anything associated "in name or referenced to" with Echo Therapeutics is enough for me to stay away! Thanks Dr. KSS and...

  • Frenchy: thanks for bringing it up. Personally, it sounds like they are trying to devise a Star Trek tricorder-like devi...

  • Om: I would still voice skepticism and doubt about FMI. No insider has ever bought a share, and insiders have been liqui...

  • Franklin: I agree. Brown is not precisely in a high-tech corridor, but a stunning number of companies are in the glucome...

  • Here's a tentative shorting list if anyone is interested. Be careful - I did it kinda fast. Maybe someone can clean it...

  • This is great news!!!! Echo Therapeutics Adds New Member to Board of Directors PHILADELPHIA, Feb. 28, 2014 /PRNewswire...

  • Brian Close: Let me help clarify a few points. ECTE is NOT targeting the diabetic market at the moment. It is target...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info